ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 88 filers reported holding ENZO BIOCHEM INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $424,000 | -4.7% | 155,460 | -3.0% | 0.00% | 0.0% |
| Q4 2018 | $445,000 | -66.3% | 160,200 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,320,000 | +56.6% | 320,400 | +97.2% | 0.00% | 0.0% |
| Q2 2018 | $843,000 | -6.2% | 162,478 | -1.0% | 0.00% | 0.0% |
| Q1 2018 | $899,000 | -32.8% | 164,099 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $1,337,000 | -20.4% | 164,099 | +2.3% | 0.00% | 0.0% |
| Q3 2017 | $1,680,000 | +1.2% | 160,457 | +6.7% | 0.00% | 0.0% |
| Q2 2017 | $1,660,000 | +40.9% | 150,354 | +6.8% | 0.00% | 0.0% |
| Q1 2017 | $1,178,000 | +51.6% | 140,745 | +25.6% | 0.00% | +100.0% |
| Q4 2016 | $777,000 | +118.9% | 112,023 | +60.7% | 0.00% | 0.0% |
| Q3 2016 | $355,000 | -4.8% | 69,721 | +11.6% | 0.00% | 0.0% |
| Q2 2016 | $373,000 | +160.8% | 62,491 | +29.1% | 0.00% | – |
| Q1 2015 | $143,000 | -33.5% | 48,392 | 0.0% | 0.00% | – |
| Q4 2014 | $215,000 | -13.7% | 48,392 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $249,000 | -2.0% | 48,392 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $254,000 | – | 48,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |